Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis

Small GTPases

Volumn 7, Issue 2, 2016, Pages 47-53

  Hongu, Tsunaki ^a   Yamauchi, Yohei ^a   Funakoshi, Yuji ^a   Katagiri, Naohiro ^a   Ohbayashi, Norihiko ^a   Kanaho, Yasunori ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Arf6; cancer cell invasion; cancer metastasis; HGF; tumor angiogenesis; tumor growth; 1 integrin recycling

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE; UVOMORULIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ADP-RIBOSYLATION FACTOR 6;

ANGIOGENESIS; CANCER GROWTH; CELL MIGRATION; ENDOCYTOSIS; EXTRACELLULAR MATRIX; HUMAN; LEWIS CARCINOMA; MELANOMA B16; METASTASIS; NOTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIUM; ANIMAL; DISEASE EXACERBATION; ENZYMOLOGY; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ADP-RIBOSYLATION FACTORS; ANIMALS; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84961905793     PISSN: 21541248     EISSN: 21541256     Source Type: Journal    
DOI: 10.1080/21541248.2016.1154640     Document Type: Note

References (59)

1. R.A.Kahn, A.G.Gilman. Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J Biol Chem 1984; 259:6228-34; PMID:6327671.
2. C.D'Souza-Schorey, P.Chavrier. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006; 7:347-58; PMID:16633337; http://dx.doi.org/10.1038/nrm1910
3. M.Tsuchiya, S.R.Price, S.C.Tsai, J.Moss, M.Vaughan. Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells. J Biol Chem 1991; 266:2772-7; PMID:1993656.
4. A.Honda, M.Nogami, T.Yokozeki, M.Yamazaki, H.Nakamura, H.Watanabe, K.Kawamoto, K.Nakayama, A.J.Morris, M.A.Frohman, etal. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 1999; 99:521-32; PMID:10589680; http://dx.doi.org/10.1016/S0092-8674(00)81540-8
5. J.Jaworski. ARF6 in the nervous system. Eur J Cell Biol 2007; 86:513-24; PMID:17559968; http://dx.doi.org/10.1016/j.ejcb.2007.04.007
6. H.Sabe. Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. J Biochem 2003; 134:485-9; PMID:14607973; http://dx.doi.org/10.1093/jb/mvg181
7. T.Hongu, Y.Kanaho. Activation machinery of the small GTPase Arf6. Adv Biol Regul 2014; 54:59-66; PMID:24139303; http://dx.doi.org/10.1016/j.jbior.2013.09.014
8. P.A.Randazzo, H.Inoue, S.Bharti. Arf GAPs as regulators of the actin cytoskeleton. Biol Cell 2014; 99:583-600; http://dx.doi.org/10.1042/BC20070034
9. J.G.Donaldson, C.L.Jackson. ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol 2011; 12:362-75; PMID:21587297; http://dx.doi.org/10.1038/nrm3117
10. M.Akiyama, M.Zhou, R.Sugimoto, T.Hongu, M.Furuya, Y.Funakoshi, M.Kato, H.Hasegawa, Y.Kanaho. Tissue- and development-dependent expression of the small GTPase Arf6 in mice. Dev Dyn 2010; 239:3416-35; PMID:21069828; http://dx.doi.org/10.1002/dvdy.22481
11. T.Suzuki, Y.Kanai, T.Hara, J.Sasaki, T.Sasaki, M.Kohara, T.Maehama, C.Taya, H.Shitara, H.Yonekawa, etal. Crucial role of the small GTPase ARF6 in hepatic cord formation during liver development. Mol Cell Biol 2006; 26:6149-56; PMID:16880525; http://dx.doi.org/10.1128/MCB.00298-06
12. C.Morgan, P.D.Lewis, L.Hopkins, S.Burnell, H.Kynaston, S.H.Doak. Increased expression of ARF GTPases in prostate cancer tissue. Springerplus 2015; 4:342; PMID:26185744; http://dx.doi.org/10.1186/s40064-015-1136-y
13. A.V.Knizhnik, O.B.Kovaleva, K.K.Laktionov, V.V.Mochal'nikova, A.V.Komel'kov, E.M.Chevkina, I.B.Zborovskaia. Arf6, RalA and BIRC5 protein expression in non small cell lung cancer. Mol Biol (Mosk) 2011; 45:307-15; PMID:21634118; http://dx.doi.org/10.1134/S0026893310061032
14. S.Oka, H.Uramoto, H.Shimokawa, S.Yamada, F.Tanaka. Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma. Oncology 2014; 86:263-70; PMID:24902879; http://dx.doi.org/10.1159/000360089
15. S.Hashimoto, Y.Onodera, A.Hashimoto, M.Tanaka, M.Hamaguchi, A.Yamada, H.Sabe. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A 2004; 101:6647-52; PMID:15087504; http://dx.doi.org/10.1073/pnas.0401753101
16. A.H.Grossmann, J.H.Yoo, J.Clancy, L.K.Sorensen, A.Sedgwick, Z.Tong, K.Ostanin, A.Rogers, K.F.Grossmann, S.R.Tripp, etal. The small GTPase ARF6 stimulates beta-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci Signal 2013; 6:ra14; PMID:23462101
17. B.Hu, B.Shi, M.J.Jarzynka, J.J.Yiin, C.D'Souza-Schorey, S.Y.Cheng. ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. Cancer Res 2009; 69:794-801; PMID:19155310; http://dx.doi.org/10.1158/0008-5472.CAN-08-2110
18. V.Muralidharan-Chari, H.Hoover, J.Clancy, J.Schweitzer, M.A.Suckow, V.Schroeder, F.J.Castellino, J.S.Schorey, C.D'Souza-Schorey. ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. Cancer Res 2009; 69:2201-9; PMID:19276388; http://dx.doi.org/10.1158/0008-5472.CAN-08-1301
19. D.X.Nguyen, P.D.Bos, J.Massague. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9:274-84; PMID:19308067; http://dx.doi.org/10.1038/nrc2622
20. F.Palacios, L.Price, J.Schweitzer, J.G.Collard, C.D'Souza-Schorey. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J 2001; 20:4973-86; PMID:11532961; http://dx.doi.org/10.1093/emboj/20.17.4973
21. F.Palacios, J.K.Schweitzer, R.L.Boshans, C.D'Souza-Schorey. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol 2002; 4:929-36; PMID:12447393; http://dx.doi.org/10.1038/ncb881
22. M.Morishige, S.Hashimoto, E.Ogawa, Y.Toda, H.Kotani, M.Hirose, S.Wei, A.Hashimoto, A.Yamada, H.Yano, etal. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol 2008; 10:85-92; PMID:18084281; http://dx.doi.org/10.1038/ncb1672
23. K.Tanabe, T.Torii, W.Natsume, S.Braesch-Andersen, T.Watanabe, M.Satake. A novel GTPase-activating protein for ARF6 directly interacts with clathrin and regulates clathrin-dependent endocytosis. Mol Biol Cell 2005; 16:1617-28; PMID:15659652; http://dx.doi.org/10.1091/mbc.E04-08-0683
24. S.Kon, K.Tanabe, T.Watanabe, H.Sabe, M.Satake. Clathrin dependent endocytosis of E-cadherin is regulated by the Arf6GAP isoform SMAP1. Exp Cell Res 2008; 314:1415-28; PMID:18331728; http://dx.doi.org/10.1016/j.yexcr.2007.11.006
25. J.K.Schweitzer, A.E.Sedgwick, C.D'Souza-Schorey. ARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasis. Semin Cell Dev Biol 2011; 22:39-47; PMID:20837153; http://dx.doi.org/10.1016/j.semcdb.2010.09.002
26. D.A.Murphy, S.A.Courtneidge. The ‘ins’ and ‘outs’ of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 2011; 12:413-26; PMID:21697900; http://dx.doi.org/10.1038/nrm3141
27. E.T.Bowden, M.Barth, D.Thomas, R.I.Glazer, S.C.Mueller. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999; 18:4440-9; PMID:10442635; http://dx.doi.org/10.1038/sj.onc.1202827
28. H.Sabe, S.Hashimoto, M.Morishige, E.Ogawa, A.Hashimoto, J.M.Nam, K.Miura, H.Yano, Y.Onodera. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic 2009; 10:982-93; PMID:19416474; http://dx.doi.org/10.1111/j.1600-0854.2009.00917.x
29. K.Hotary, X.Y.Li, E.Allen, S.L.Stevens, S.J.Weiss. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 2006; 20:2673-86; PMID:16983145; http://dx.doi.org/10.1101/gad.1451806
30. A.Steffen, G.Le Dez, R.Poincloux, C.Recchi, P.Nassoy, K.Rottner, T.Galli, P.Chavrier. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7. Curr Biol 2008; 18:926-31; PMID:18571410; http://dx.doi.org/10.1016/j.cub.2008.05.044
31. E.Frittoli, A.Palamidessi, P.Marighetti, S.Confalonieri, F.Bianchi, C.Malinverno, G.Mazzarol, G.Viale, I.Martin-Padura, M.Garré, etal. A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination. J Cell Biol 2014; 206:307-28; PMID:25049275; http://dx.doi.org/10.1083/jcb.201403127
32. Y.V.Loskutov, P.Y.Kozyulina, V.K.Kozyreva, R.J.Ice, B.C.Jones, T.J.Roston, M.B.Smolkin, A.V.Ivanov, R.B.Wysolmerski, E.N.Pugacheva. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer. Oncogene 2015; 34:3662-75; PMID:25241893; http://dx.doi.org/10.1038/onc.2014.297
33. V.Marchesin, A.Castro-Castro, C.Lodillinsky, A.Castagnino, J.Cyrta, H.Bonsang-Kitzis, L.Fuhrmann, M.Irondelle, E.Infante, G.Montagnac, etal. ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion. J Cell Biol 2015; 211:339-58; PMID:26504170; http://dx.doi.org/10.1083/jcb.201506002
34. C.D'Souza-Schorey, J.W.Clancy. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012; 26:1287-99; PMID:22713869; http://dx.doi.org/10.1101/gad.192351.112
35. V.Muralidharan-Chari, J.Clancy, C.Plou, M.Romao, P.Chavrier, G.Raposo, C.D'Souza-Schorey. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 2009; 19:1875-85; PMID:19896381; http://dx.doi.org/10.1016/j.cub.2009.09.059
36. Z.Hu, R.Xu, J.Liu, Y.Zhang, J.Du, W.Li, W.Zhang, Y.Li, Y.Zhu, L.Gu. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway. Exp Cell Res 2013; 319:1932-41; PMID:2374771; http://dx.doi.org/10.1016/j.yexcr.2013.05.028
37. M.Li, S.S.Ng, J.Wang, L.Lai, S.Y.Leung, M.Franco, Y.Peng, M.L.He, H.F.Kung, M.C.Lin. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling. Cancer Res 2006; 66:1583-90; PMID:16452216; http://dx.doi.org/10.1158/0008-5472.CAN-05-2424
38. D.F.Quail, J.A.Joyce. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19:1423-37; PMID:24202395; http://dx.doi.org/10.1038/nm.3394
39. D.Hanahan, R.A.Weinberg. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
40. P.Carmeliet, R.K.Jain. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473:298-307; PMID:21593862; http://dx.doi.org/10.1038/nature10144
41. Y.Y.Kisanuki, R.E.Hammer, J.Miyazaki, S.C.Williams, J.A.Richardson, M.Yanagisawa. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 2001; 230:230-42; PMID:11161575; http://dx.doi.org/10.1006/dbio.2000.0106
42. T.Hongu, Y.Funakoshi, S.Fukuhara, T.Suzuki, S.Sakimoto, N.Takakura, M.Ema, S.Takahashi, S.Itoh, M.Kato, etal. Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial beta1 integrin recycling. Nat Commun 2015; 6:7925; PMID:26239146; http://dx.doi.org/10.1038/ncomms8925
43. F.Nussenbaum, I.M.Herman. Tumor angiogenesis: insights and innovations. J Oncol 2010; 2010:132641; PMID:20445741; http://dx.doi.org/10.1155/2010/132641
44. M.Montag, G.Dyckhoff, J.Lohr, B.M.Helmke, E.Herrmann, P.K.Plinkert, C.Herold-Mende. Angiogenic growth factors in tissue homogenates of HNSCC: expression pattern, prognostic relevance, and interrelationships. Cancer Sci 2009; 100:1210-8; PMID:19385965; http://dx.doi.org/10.1111/j.1349-7006.2009.01158.x
45. W.Shioyama, Y.Nakaoka, K.Higuchi, T.Minami, Y.Taniyama, K.Nishida, H.Kidoya, T.Sonobe, H.Naito, Y.Arita, etal. Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-met signaling. Circ Res 2011; 108:664-75; PMID:21293003; http://dx.doi.org/10.1161/CIRCRESAHA.110.232223
46. P.Carmeliet, V.Ferreira, G.Breier, S.Pollefeyt, L.Kieckens, M.Gertsenstein, M.Fahrig, A.Vandenhoeck, K.Harpal, C.Eberhardt, etal. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380:435-39; PMID:8602241; http://dx.doi.org/10.1038/380435a0
47. N.Ferrara, K.Carver-Moore, H.Chen, M.Dowd, L.Lu, K.S.O′Shea, L.Powell-Braxton, K.J.Hillan, M.W.Moore. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-42; PMID:8602242; http://dx.doi.org/10.1038/380439a0
48. A.Hashimoto, S.Hashimoto, R.Ando, K.Noda, E.Ogawa, H.Kotani, M.Hirose, T.Menju, M.Morishige, T.Manabe, etal. GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. PLoS One 2011; 6:e23359; PMID:21858086; http://dx.doi.org/10.1371/journal.pone.0023359
49. S.Ikeda, M.Ushio-Fukai, L.Zuo, T.Tojo, S.Dikalov, N.A.Patrushev, R.W.Alexander. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2005; 96:467-75; PMID:15692085; http://dx.doi.org/10.1161/01.RES.0000158286.51045.16
50. R.Silva, G.D'Amico, K.M.Hodivala-Dilke, L.E.Reynolds. Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol 2008; 28:1703-13; PMID:18658045; http://dx.doi.org/10.1161/ATVBAHA.108.172015
51. A.M.Powelka, J.Sun, J.Li, M.Gao, L.M.Shaw, A.Sonnenberg, V.W.Hsu. Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 2004; 5:20-36; PMID:14675422; http://dx.doi.org/10.1111/j.1600-0854.2004.00150.x
52. J.Li, A.W.Malaby, M.Famulok, H.Sabe, D.G.Lambright, V.W.Hsu. Grp1 plays a key role in linking insulin signaling to glut4 recycling. Dev Cell 2012; 22:1286-98; PMID:22609160; http://dx.doi.org/10.1016/j.devcel.2012.03.004
53. R.Grepin, G.Pages. Molecular mechanisms of resistance to tumor anti-angiogenic strategies. J Oncol 2010; 2010:835680; PMID:20224655; http://dx.doi.org/10.1155/2010/835680
54. D.Ribatti. Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway. Cancer Treat Rev 2011; 37:344-52; PMID:21435792; http://dx.doi.org/10.1016/j.ctrv.2011.02.002
55. F.Shojaei, J.H.Lee, B.H.Simmons, A.Wong, C.O.Esparza, P.A.Plumlee, J.Feng, A.E.Stewart, D.D.Hu-Lowe, J.G.Christensen. HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res 2010; 70:10090-100; PMID:20952508; http://dx.doi.org/10.1158/0008-5472.CAN-10-0489
56. M.Paez-Ribes, E.Allen, J.Hudock, T.Takeda, H.Okuyama, F.Vinals, M.Inoue, G.Bergers, D.Hanahan, O.Casanovas. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15:220-31; PMID:19249680; http://dx.doi.org/10.1016/j.ccr.2009.01.027
57. J.M.Ebos, C.R.Lee, W.Cruz-Munoz, G.A.Bjarnason, J.G.Christensen, R.S.Kerbel. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009; 15:232-9; PMID:19249681; http://dx.doi.org/10.1016/j.ccr.2009.01.021
58. M.Hafner, A.Schmitz, I.Grune, S.G.Srivatsan, B.Paul, W.Kolanus, T.Quast, E.Kremmer, I.Bauer, M.Famulok. Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 2006; 444:941-4; PMID:17167487; http://dx.doi.org/10.1038/nature05415
59. B.Miao, I.Skidan, J.Yang, Z.You, X.Fu, M.Famulok, B.Schaffhausen, V.Torchilin, J.Yuan, A.Degterev. Inhibition of cell migration by PITENINs: the role of ARF6. Oncogene 2012; 31:4317-32; PMID:22179837; http://dx.doi.org/10.1038/onc.2011.593